Bedier, H. et al. (2023) “Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19”, European Journal of Case Reports in Internal Medicine, 10(12). doi:10.12890/2023_004098.